TRACON to Announce Q1 2024 Financial Results and Corporate Update on May 14, 2024

SAN DIEGO, May 07, 2024 – TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical-stage biopharmaceutical firm, has announced it will disclose its financial and operational results for the first quarter of 2024 after the U.S. financial markets close on Tuesday, May 14, 2024. Following the announcement, the company’s management will host a conference call to discuss corporate activities and the financial outcomes.

The conference call is scheduled for May 14, 2024, at 4:30 PM Eastern Time (1:30 PM Pacific Time). Participants need to register in advance and will receive an email with the necessary dial-in details and a unique access code after registration. To avoid any connection issues, TRACON recommends registering at least 10 minutes before the call starts. Those who do not intend to ask questions during the call are advised to listen via the webcast. The webcast will be accessible through TRACON’s website, where a replay will be available for 60 days.

TRACON Pharmaceuticals is focused on advancing its portfolio of innovative cancer treatments using a cost-efficient, CRO-independent product development platform. Their clinical-stage pipeline includes several key drug candidates. Envafolimab, a PD-L1 single-domain antibody administered through a rapid subcutaneous injection, is currently undergoing pivotal trials for sarcoma under the ENVASARC study. Another promising candidate is YH001, which is a potential best-in-class CTLA-4 antibody in Phase 1 trials. Additionally, TRC102 is a small molecule drug candidate in Phase 2 development aimed at treating lung cancer.

The company is actively looking for new corporate partnerships. These could be in the form of profit-share or revenue-share arrangements, or through franchising its product development platform. TRACON aims to provide solutions for other companies that lack clinical and commercial capabilities in the U.S. or desire to achieve CRO-independence.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!